HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$7.62
Day range
$7.41 - $7.60
Year range
$5.20 - $11.35
Market cap
547.22M USD
Avg Volume
60.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.71M | -35.08% |
Net income | -20.31M | 12.08% |
Net profit margin | — | — |
Earnings per share | -2.78 | 13.13% |
EBITDA | -21.69M | 14.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 148.39M | -32.00% |
Total assets | 164.09M | -34.19% |
Total liabilities | 30.04M | -9.89% |
Total equity | 134.05M | — |
Shares outstanding | 7.30M | — |
Price to book | 0.41 | — |
Return on assets | -31.90% | — |
Return on capital | -34.37% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.31M | 12.08% |
Cash from operations | -17.49M | 13.42% |
Cash from investing | 24.06M | 29.54% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 6.58M | 508.57% |
Free cash flow | -13.54M | -13.34% |
About
Founded
2015
Headquarters
Website
Employees
58
